Acknowledgement
Supported by : Ministry of Health & Welfare
References
- Przyrembel H, Wendel U, Becker K, Bremer HJ, Bruinvis L, Ketting D, et al. Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clin Chim Acta 1976;66:227-39. https://doi.org/10.1016/0009-8981(76)90060-7
- Lindner M, Hoffmann GF, Matern D. Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting. J Inherit Metab Dis 2010;33:521-6. https://doi.org/10.1007/s10545-010-9076-8
- Grunert SC. Clinical and genetical heterogeneity of late-onset multiple acyl-coenzyme A dehydrogenase deficiency. Orphanet J Rare Dis 2014; 9:117. https://doi.org/10.1186/s13023-014-0117-5
- Lehnert W, Wendel U, Lindenmaier S, Bohm N. Multiple acyl-CoA dehydrogenation deficiency (glutaric aciduria type II), congenital polycystic kidneys, and symmetric warty dysplasia of the cerebral cortex in two brothers. Europ J Pediat 1982;139:56-9. https://doi.org/10.1007/BF00442081
- Al-Essa MA, Rashed MS, Bakheet SM, Patay ZJ, Ozand PT. Glutaric aciduria type II: observations in seven patients with neonatal- and late-onset disease. J Perinatol 2000;2:120-8.
- Olsen RK, Olpin SE, Andresen BS, Miedzybrodzka ZH, Pourfarzam M, Merinero B, et al. ETFDH mutations as a major cause of riboflavin-responsive multiple acyl-CoA dehydrogenation deficiency. Brain 2007; 130:2045-54. https://doi.org/10.1093/brain/awm135
- Chen M, Peng J, Wei W, Wang R, Xu H, Liu H. A novel ETFDH mutation in an adult patient with late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency. Int J Neurosci 2018;128:291-4. https://doi.org/10.1080/00207454.2017.1380641
- Yotsumoto Y, Hasegawa Y, Fukuda S, Kobayashi H, Endo M, Fukao T, et al. Clinical and molecular investigations of Japanese cases of glutaric acidemia type 2. Mol Genet Metab 2008;94:61-7. https://doi.org/10.1016/j.ymgme.2008.01.002
- Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;402-8.
- Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015;17:405-24. https://doi.org/10.1038/gim.2015.30
Cited by
- Late-onset riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency (MADD): case reports and epidemiology of ETFDH gene mutations vol.19, pp.1, 2018, https://doi.org/10.1186/s12883-019-1562-5
- Role of RNA in Molecular Diagnosis of MADD Patients vol.9, pp.5, 2018, https://doi.org/10.3390/biomedicines9050507
- Targeted Therapies for Metabolic Myopathies Related to Glycogen Storage and Lipid Metabolism: a Systematic Review and Steps Towards a ‘Treatabolome’ vol.8, pp.3, 2018, https://doi.org/10.3233/jnd-200621
- ETF dehydrogenase advances in molecular genetics and impact on treatment vol.56, pp.4, 2018, https://doi.org/10.1080/10409238.2021.1908952